Provided by Tiger Trade Technology Pte. Ltd.

Invesco Nasdaq Biotechnology ETF

34.62
+0.99512.96%
Volume:31.48K
Turnover:1.09M
Market Cap:111.48M
PE:- -
High:34.68
Open:33.80
Low:33.71
Close:33.62
52wk High:36.84
52wk Low:25.00
Shares:3.22M
Float Shares:3.22M
Volume Ratio:0.39
T/O Rate:0.98%
Dividend:0.39
Dividend Rate:1.13%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Oct 08

Moderna Inc. Stock Rises 4.8%, Outperforms Peers

Dow Jones
·
Oct 08

Vertex to Report Q3 2026 Financial Results, Host Conference Call and Webcast

Reuters
·
Oct 08

NASDAQ Top and Bottom Performing Stocks at About 02:45 P.m. EDT on 2026-10-07

Reuters
·
Oct 08

Amgen Inc Stock (AMGN) Moved Up by 3.06% on Oct 7: A Full Analysis

TradingKey
·
Oct 08

Regeneron Pharma Price Target Raised to $779.00/Share from $758.00 by Morgan Stanley

Dow Jones
·
Oct 07

Amgen is Maintained at Equal-Weight by Morgan Stanley

Dow Jones
·
Oct 07

Former Gilead and Amgen Commercial Leader Laura Hamill Just Joined Entera (NASDAQ: ENTX)

TIPRANKS
·
Oct 07

Early notable gainers among liquid option names on October 7th

TIPRANKS
·
Oct 07

J.P. Morgan Remains a Buy on Gilead Sciences (GILD)

TIPRANKS
·
Oct 07

Innovative drug stock with 300% gain issues risk warning after severe price anomaly

Deep News
·
Oct 07

Changchun High-Tech's Subsidiary Receives Approval for GenSci155 Injection Clinical Trial Application

Stock News
·
Oct 07

Beijing Centergate Subsidiary Wins Clinical Trial Approval for BDB Tablet

Stock News
·
Oct 07

StemRIM Wins U.S. Patent for Stem Cell Gene Therapy Targeting Rare Skin Disease

TIPRANKS
·
Oct 07

Gilead : JP Morgan Raises Target Price to $170 from $160

THOMSON REUTERS
·
Oct 07

Moderna Inc. Stock Slips 7.8%, Underperforms Peers

Dow Jones
·
Oct 07

Amgen’s AMG 513 Obesity Trial Reaches Phase 1 Completion, Adding a New Angle to the Weight-Loss Drug Race

TIPRANKS
·
Oct 07

Cognizant, Gilead Sign 5-Year Tech Extension Covering DevOps, AI Tools

MT Newswires Live
·
Oct 06

Cognizant announces five-year extension of its work with Gilead Sciences

TIPRANKS
·
Oct 06

Cognizant - to Support Gilead's Devops and AI Tools Across Selected Technology Programs

THOMSON REUTERS
·
Oct 06